Profile data is unavailable for this security.
About the company
Hyuga Primary Care Co Ltd is a Japan-based company mainly engaged in the provision of home-visit pharmacy services, discharge support services and care plan services for home-based patients. The Company operates through four business segments. The Home-visit Pharmacy segment is engaged in the delivery of medicines to outpatients and home-based patients based on prescriptions issued by medical institutions. The Kirari Prime segment is engaged in the provision of know-how and information systems to collaborative pharmacies. The Care Plan segment is engaged in the provision of care planning services, as well as contact and coordinate services with each service offices. The Taisapo segment is engaged in the provision of discharged patient introduction services for nursing care facilities. The Company is also engaged in the development and sale of wearable devices for long-term care facilities, and other information and communication technology (ICT) business.
- Revenue in JPY (TTM)9.11bn
- Net income in JPY597.71m
- Incorporated2007
- Employees544.00
- LocationHyuga Primary Care Co Ltd2-2-1, Kasugabarukita-machiKASUGA-SHI 816-0802JapanJPN
- Phone+81 925582120
- Fax+81 925582121
- Websitehttps://www.hyuga-primary.care/
Mergers & acquisitions
Acquired company | 7133:TYO since announced | Transaction value |
---|---|---|
Medical Mind | -28.61% | 3.51m |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sophia Holdings Co Ltd | 8.69bn | -88.57m | 5.06bn | 193.00 | -- | 1.53 | 17.14 | 0.5817 | -23.30 | -23.30 | 2,196.89 | 707.64 | 1.19 | 10.27 | 7.21 | 45,041,210.00 | -1.21 | 2.93 | -2.04 | 5.09 | 37.86 | 35.07 | -1.02 | 2.32 | 1.46 | 5.48 | 0.3885 | 0.00 | -4.14 | 14.77 | -577.93 | -- | -12.58 | -- |
Hyuga Primary Care Co Ltd | 9.11bn | 597.71m | 9.26bn | 544.00 | 15.78 | 4.69 | 10.98 | 1.02 | 80.97 | 80.97 | 1,233.61 | 272.47 | 1.68 | 28.57 | 5.94 | 16,739,020.00 | 11.00 | -- | 17.91 | -- | 23.86 | -- | 6.56 | -- | 1.17 | 42.91 | 0.5954 | -- | 24.46 | -- | 15.19 | -- | -- | -- |
Healthlead PCL | 8.48bn | 343.98m | 10.30bn | 484.00 | 29.94 | 2.36 | 15.54 | 1.21 | 0.2822 | 0.2822 | 6.96 | 3.58 | 1.35 | 5.26 | 157.16 | -- | 5.49 | 9.00 | 6.45 | 11.24 | 23.28 | 22.77 | 4.06 | 5.46 | 2.26 | 23.13 | 0.2292 | -- | 7.64 | -- | -36.84 | -- | -- | -- |
Satudora Holdings Co Ltd | 96.62bn | 481.00m | 11.32bn | 1.11k | 22.84 | 1.21 | 6.19 | 0.1171 | 34.80 | 34.80 | 6,987.78 | 656.46 | 2.15 | 6.81 | 33.48 | 87,282,740.00 | 1.10 | 0.797 | 2.20 | 1.49 | 24.84 | 24.39 | 0.5133 | 0.3631 | 0.4631 | 12.17 | 0.6287 | 42.25 | 9.19 | 2.45 | 440.23 | 74.56 | -5.88 | 1.39 |
Medical System Network Co Ltd | 118.66bn | 1.21bn | 12.72bn | 3.74k | 10.30 | 0.7977 | 2.81 | 0.1072 | 40.30 | 40.30 | 4,009.56 | 520.24 | 1.74 | 11.44 | 29.75 | 31,693,640.00 | 1.80 | 2.19 | 2.86 | 3.35 | 41.41 | 40.83 | 1.04 | 1.33 | 0.5612 | 12.25 | 0.6217 | 23.75 | 5.30 | 3.27 | 15.53 | 32.12 | -7.85 | 3.71 |
Dingdang Health Technology Group Ltd | 104.73bn | -4.25bn | 15.81bn | 2.51k | -- | 0.3784 | -- | 0.1509 | -0.1598 | -0.1598 | 3.95 | 1.56 | 1.57 | 5.61 | 43.27 | 2,005,498.00 | -6.53 | -55.91 | -9.42 | -82.51 | 32.38 | 32.74 | -4.17 | -35.83 | 1.86 | -- | 0.0766 | -- | 12.19 | 52.72 | 92.03 | -- | 13.40 | -- |
Sunshine Holdings PLC | 30.68bn | 2.18bn | 19.45bn | 1.70k | 8.93 | 1.84 | 5.82 | 0.6339 | 8.29 | 8.29 | 116.75 | 40.23 | 1.34 | 3.43 | 5.06 | 33,721,690.00 | 12.34 | 12.87 | 22.68 | 23.74 | 30.58 | 29.69 | 9.24 | 10.29 | 1.09 | 15.66 | 0.2783 | 16.93 | 7.03 | 19.65 | 97.49 | 47.20 | -5.69 | 48.41 |
Charmacy Pharmaceutical Co Ltd | 96.23bn | 1.11bn | 20.49bn | 834.00 | 18.44 | 1.61 | 11.76 | 0.2129 | 0.5152 | 0.5152 | 44.62 | 5.90 | 1.47 | 5.49 | 4.76 | 5,798,960.00 | 1.70 | 1.79 | 8.48 | 7.99 | 6.91 | 6.16 | 1.15 | 1.24 | 0.7714 | 2.44 | 0.5882 | 37.09 | 5.47 | 2.27 | -43.25 | 2.48 | -16.01 | 0.0027 |
Kimia Farma Tbk PT | 99.09bn | -16.76bn | 33.27bn | 10.71k | -- | 0.6369 | -- | 0.3357 | -307.59 | -311.08 | 1,817.52 | 957.72 | 0.5415 | 2.78 | 4.36 | 882,472,800.00 | -11.90 | -1.82 | -23.42 | -3.22 | 24.05 | 35.14 | -21.98 | -3.08 | 0.4154 | -3.76 | 0.5702 | -- | 7.93 | 3.33 | -737.71 | -- | -9.87 | -- |
Holder | Shares | % Held |
---|---|---|
Asset Management One Co., Ltd.as of 15 Oct 2024 | 443.00k | 6.11% |
Ichiyoshi Asset Management Co., Ltd.as of 21 Aug 2023 | 98.80k | 1.36% |
Meiji Yasuda Asset Management Co. Ltd.as of 14 Aug 2023 | 95.40k | 1.32% |
Nikko Asset Management Co., Ltd.as of 18 Jul 2023 | 66.00k | 0.91% |
SBI Asset Management Co., Ltd.as of 22 Jun 2023 | 37.60k | 0.52% |
Nomura Asset Management Co., Ltd.as of 31 Oct 2022 | 32.60k | 0.45% |
Simplex Asset Management Co., Ltd.as of 07 Nov 2024 | 8.70k | 0.12% |
SEB Investment Management ABas of 28 Feb 2022 | 4.20k | 0.06% |
Asset Management One International Ltd.as of 15 Feb 2024 | 4.00k | 0.06% |
Sumitomo Mitsui DS Asset Management Co., Ltd.as of 26 Jan 2023 | 1.40k | 0.02% |